Anticancer therapies in specialized palliative care--a multicenter survey.

Szczegóły
Abstrakt

Tytuł:: Anticancer therapies in specialized palliative care--a multicenter survey.
Autorzy:: Alt-Epping B; Department of Palliative Medicine, University Medical Center, Göttingen, Germany. />Pache S
Lindena G
Nauck F
Corporate Authors:: German Hospice and Palliative Care Evaluation (HOPE) Working Group
Źródło:: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2012 Oct; Vol. 20 (10), pp. 2385-9. Date of Electronic Publication: 2011 Dec 24.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Original Publication: Berlin : Springer International, c1993-
MeSH Terms:: Palliative Care*
Antineoplastic Agents/*therapeutic use
Neoplasms/*drug therapy
Aged ; Aged, 80 and over ; Female ; Germany ; Health Care Surveys ; Humans ; Male ; Middle Aged ; Neoplasms/physiopathology ; Prospective Studies
References:: Am J Clin Oncol. 1982 Dec;5(6):649-55. (PMID: 7165009)
J Pain Symptom Manage. 2002 Jun;23(6):471-83. (PMID: 12067771)
Br J Cancer. 1995 Feb;71(2):366-70. (PMID: 7530988)
J Clin Oncol. 2004 Jan 15;22(2):315-21. (PMID: 14722041)
J Clin Oncol. 2006 Jun 20;24(18):2828-35. (PMID: 16782921)
Support Care Cancer. 1999 May;7(3):128-33. (PMID: 10335930)
J Clin Oncol. 1997 Jun;15(6):2403-13. (PMID: 9196156)
Lung Cancer. 2008 Apr;60(1):113-124. (PMID: 17976859)
Z Arztl Fortbild Qualitatssich. 2005;99(9):555-65. (PMID: 16398197)
J Clin Oncol. 2008 Aug 10;26(23):3860-6. (PMID: 18688053)
J Clin Oncol. 2011 Feb 20;29(6):755-60. (PMID: 21263086)
J Clin Oncol. 2006 Dec 1;24(34):5441-7. (PMID: 17135646)
J Clin Oncol. 2009 Jun 20;27(18):3052-8. (PMID: 19451437)
J Palliat Care. 1996 Spring;12(1):5-11. (PMID: 8857241)
N Engl J Med. 2010 Aug 19;363(8):733-42. (PMID: 20818875)
Substance Nomenclature:: 0 (Antineoplastic Agents)
Entry Date(s):: Date Created: 20111227 Date Completed: 20130328 Latest Revision: 20220318
Update Code:: 20240104
PubMed Central ID:: PMC3430838
DOI:: 10.1007/s00520-011-1349-8
PMID:: 22198166
: Czasopismo naukowe

Full Text Finder

Introduction: Anticancer therapies gain increasing attention and discussion in specialized palliative care institutions. Frequency, indication, attitude of team members, and modes of these therapies implemented in specialized palliative care settings are still under investigation.
Methods: Descriptive analysis of the nationwide Hospice and Palliative Care Evaluation 2007 that collected data from palliative medicine, hospice care, and oncology institutions concerning the use of anticancer therapies.
Results: Three thousand one hundred eighty-four patients from 67 palliative care units, eight oncology wards, and other in- and outpatient institutions were registered. Two hundred eleven therapeutic interventions, mostly i.v. chemotherapy (28.9%), have been documented in all institutions except from inpatient hospices. Although all institutions were asked to keep records from "palliative patients", those patients treated in oncology services differed from patients on palliative care units with respect to prognosis, therapeutic intention (symptom control versus tumor remission), and team attitude.
Discussion: Anticancer therapies are incorporated into palliative care concepts. The described differences in palliative patients that are treated in specialized palliative care as compared to oncology services will have to be discussed with regard to selection of patients for specialized palliative care and the range of suitable treatment modalities in palliative care concepts.

Informacja